VANESSA SCHIAFONE: Open Payments
NPI 1952053217 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 37 payments from 13 companies in 2025. Trend: 2023 $50 · 2024 $42 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $201 |
| Endo USA, Inc. | 4 | $180 |
| ABBVIE INC. | 6 | $142 |
| PFIZER INC. | 6 | $120 |
| Sumitomo Pharma America, Inc. | 2 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| UROGEN PHARMA, INC. | 3 | $64 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Procept Biorobotics Corporation | 1 | $43 |
| Astellas Pharma US Inc | 1 | $36 |
Products named: ERLEADA, XTANDI, BOTOX, XIAFLEX, ORGOVYX, Nubeqa, AVEED, ADSTILADRIN.
Industry payments across TX — which companies pay providers there.
